Icosavax (ICVX) News Today → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free ICVX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHead-To-Head Analysis: Icosavax (NASDAQ:ICVX) vs. Eupraxia Pharmaceuticals (OTCMKTS:EPRXF)americanbankingnews.com - April 13 at 2:28 AMCHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)markets.businessinsider.com - March 20 at 5:38 PMmarketbeat.com - February 19 at 6:09 AMIcosavax, Inc. (NASDAQ:ICVX) Shares Bought by Barclays PLCmarketbeat.com - February 17 at 5:27 AMIcosavax: Tender Offer With Contingent Value Rightseekingalpha.com - February 11 at 10:30 AMIcosavax, Inc. (NASDAQ:ICVX) CEO Sells $229,350.00 in Stockmarketbeat.com - February 2 at 9:18 PMIcosavax CVR Seems Fairly Valuedseekingalpha.com - January 5 at 3:45 PMAdam K. Simpson Sells 15,000 Shares of Icosavax, Inc. (NASDAQ:ICVX) Stockmarketbeat.com - January 4 at 7:22 PMGuggenheim Downgrades Icosavax (ICVX)msn.com - January 2 at 8:59 PMIcosavax's (ICVX) "Neutral" Rating Reiterated at Guggenheimmarketbeat.com - January 2 at 8:18 AMICOSAVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Icosavax, Inc. - ICVXbusinesswire.com - December 31 at 11:37 PMChief Medical Officer Niranjan Kanesa-thasan Sells 11,884 Shares of Icosavax Inc (ICVX)finance.yahoo.com - December 24 at 7:08 AMInsider Selling: Icosavax, Inc. (NASDAQ:ICVX) Insider Sells 11,884 Shares of Stockmarketbeat.com - December 22 at 9:28 PMICVX Jul 2024 15.000 callca.finance.yahoo.com - December 18 at 4:46 AMIcosavax, Inc. (NASDAQ:ICVX) Short Interest Down 5.6% in Novembermarketbeat.com - December 18 at 3:17 AMInsider Sell Alert: Chief Business Officer Cassia Cearley Sells 8,759 Shares of Icosavax Inc (ICVX)finance.yahoo.com - December 16 at 12:53 PMCassia Cearley Sells 8,759 Shares of Icosavax, Inc. (NASDAQ:ICVX) Stockmarketbeat.com - December 15 at 9:23 PMIcosavax (NASDAQ:ICVX) Downgraded by William Blairmarketbeat.com - December 14 at 6:51 AMIcosavax, Inc. (ICVX) Is Up 0.10% in One Week: What You Should Knowfinance.yahoo.com - December 13 at 3:48 PMIcosavax, Inc. (ICVX) Moves to Buy: Rationale Behind the Upgradefinance.yahoo.com - December 13 at 3:48 PMIcosavax just downgraded at Jefferies, here's whyrealmoney.thestreet.com - December 12 at 11:04 PMIcosavax deal CVR based on FDA approval for IVX-A12, sales in EU, UK, Canadamsn.com - December 12 at 11:04 PMIcosavax just downgraded at William Blair, here's whyrealmoney.thestreet.com - December 12 at 6:04 PMShareholder Alert: Ademi LLP investigates whether Icosavax, Inc. has obtained a Fair Price in its transaction with AstraZenecastockhouse.com - December 12 at 1:03 PMICVX STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Icosavax, Inc. Is Fair to Shareholderstmcnet.com - December 12 at 1:03 PMWhy Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarketmarkets.businessinsider.com - December 12 at 1:03 PMAstraZeneca to acquire vaccine maker Icosavax in ~$1.1B dealmsn.com - December 12 at 8:02 AMIcosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adultsfinance.yahoo.com - December 12 at 8:02 AMIcosavax, Inc. Announces Agreement to be Acquired by AstraZenecafinance.yahoo.com - December 12 at 8:02 AMWall Street Analysts Believe Icosavax, Inc. (ICVX) Could Rally 175.87%: Here's is How to Tradefinance.yahoo.com - December 8 at 3:42 PMIcosavax, Inc. (ICVX) is on the Move, Here's Why the Trend Could be Sustainablefinance.yahoo.com - December 4 at 2:54 PMIcosavax (ICVX) Price Target Increased by 5.00% to 24.99msn.com - November 27 at 4:55 PMGuggenheim Initiates Coverage of Icosavax (ICVX) with Buy Recommendationmsn.com - November 18 at 9:14 AMIcosavax initiated with a Buy at Guggenheimrealmoney.thestreet.com - November 17 at 12:36 PMTD Cowen Keeps Their Buy Rating on Icosavax (ICVX)markets.businessinsider.com - November 16 at 10:22 AMTarget Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesdaymarkets.businessinsider.com - November 15 at 1:07 PMIcosavax, Inc.: Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 15 at 8:07 AMIcosavax Inc (ICVX) Reports Q3 2023 Financial Results and Corporate Progressfinance.yahoo.com - November 14 at 10:07 PMIcosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 5:06 PMAura Biosciences GAAP EPS of -$0.48seekingalpha.com - November 10 at 8:45 AMIcosavax to Participate in the Jefferies London Healthcare Conferencefinance.yahoo.com - November 8 at 8:58 AMIcosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conferencefinance.yahoo.com - October 31 at 1:02 PMWe're Not Very Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Ratefinance.yahoo.com - October 30 at 9:34 AMIcosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023finance.yahoo.com - September 19 at 8:32 AMTower Research Capital LLC TRC Acquires 20,910 Shares of Icosavax, Inc. (NASDAQ:ICVX)marketbeat.com - September 1 at 4:36 AMJefferies Reaffirms Their Buy Rating on Icosavax (ICVX)markets.businessinsider.com - August 15 at 5:02 PMIcosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 6:08 PMIcosavax Reports Positive 12-Month Durability Data for VLP Vaccine Candidate IVX-121 Against RSV and Initial Evidence for Revaccination Potentialfinance.yahoo.com - August 8 at 4:37 PMETF Managers Group LLC Takes Position in Icosavax, Inc. (NASDAQ:ICVX)marketbeat.com - July 3 at 5:16 AMIcosavax, Inc. (NASDAQ:ICVX) is largely controlled by institutional shareholders who own 53% of the companyfinance.yahoo.com - July 2 at 9:45 AM Get Icosavax News Delivered to You Automatically Sign up to receive the latest news and ratings for ICVX and its competitors with MarketBeat's FREE daily newsletter. Email Address You’re invited: Biggest crypto event of 2024 (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. ICVX Media Mentions By Week ICVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICVX News Sentiment▼0.000.53▲Average Medical News Sentiment ICVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICVX Articles This Week▼11▲ICVX Articles Average Week Get Icosavax News Delivered to You Automatically Sign up to receive the latest news and ratings for ICVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Gracell Biotechnologies News Arcturus Therapeutics News Stoke Therapeutics News Monte Rosa Therapeutics News Harpoon Therapeutics News Invivyd News Enanta Pharmaceuticals News Akebia Therapeutics News Prothena News Zevra Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICVX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icosavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.